Call for Abstract

16th International Congress on Dermatology Practices, will be organized around the theme “New approaches in advancements in skin therapeutics”

Cutaneous Neoplasms 2019 is comprised of keynote and speakers sessions on latest cutting edge research designed to offer comprehensive global discussions that address current issues in Cutaneous Neoplasms 2019

Submit your abstract to any of the mentioned tracks.

Register now for the conference by choosing an appropriate package suitable to you.

A neoplasm is an abnormal mass of tissue, the growth of which exceeds and is uncoordinated with that of normal tissues and persists in the same excessive manner after cessation of the stimuli that evoke the change. In contrast to normal cells, the growth of neoplastic cells is:

Autonomous: The growth of neoplastic cells is independent of growth factors and regulatory mechanisms operating inside the normal tissues.

Excessive: This excess may be evident in the size of the outgrowths and the duration of the proliferation.

Disorganized: The structures formed by tumour cells differ from normal tissues and do not fit into the general organization scheme of the normal body.

  • Track 1-1Cell Cycle Control and Genetic Instability
  • Track 1-2Clonality of Neoplasms
  • Track 1-3Benign Neoplasm
  • Track 1-4Cystic endocrine neoplasms
  • Track 1-5Premalignant neoplasms
  • Track 1-6Malignant neoplasms
  • Track 1-7Hamartomas and Choristomas
  • Track 1-8Metaplasia
  • Track 1-9Hyperlasia and Dysplasia

The spectrum of cutaneous malignancies of the head and neck ranges from tumours that are fairly well behaved, such as the majority of basal cell carcinomas, to very aggressive cancers with a high metastatic rate, such as Merkel cell carcinoma. Most forms of cutaneous malignancy have characteristic clinical presentations, which assist in their clinical diagnosis. The goal of this article is to review the appearances and clinical presentations of common non melanoma skin cancers (basal and squamous cell carcinomas), uncommon non melanoma skin cancers (Merkel cell carcinoma and dermatofibrosarcoma protuberans), and the various subtypes of cutaneous melanoma.

  • Track 2-1Incidence and Epidemiology
  • Track 2-2Normal Skin Histology
  • Track 2-3Basal Cell Carcinoma
  • Track 2-4Squamous Cell Carcinoma
  • Track 2-5Treatment of Cutaneous Malignancy
  • Track 2-6Rare Cutaneous Malignancies

Cutaneous lymphoma is a rare type of cancer that begins in white blood cells called T cells (T lymphocytes). These cells normally help your body's germ-fighting immune system. In cutaneous T-cell lymphoma, the T cells develop abnormalities that make them attack the skin.

  • Track 3-1Cutaneous T-Cell Lymphomas
  • Track 3-2Cutaneous B-Cell Lymphomas
  • Track 3-3Primary cutaneous lymphoma
  • Track 3-4Mycosis fungoides
  • Track 3-5Sezary syndrome
  • Track 3-6Chemotherapy

A dark band in the nail may be the initial sign of malignant melanoma of the nail. Pigment cells of the nail-making tissue, known as the nail matrix, may become malignant and develop into a melanoma. A worrisome sign is known as "Hutchinson" sign. The Hutchinson sign is black, brown, or grey discoloration that extends to the area around the nail, such as the cuticle or nail fold (the fold of hard skin at the sides of the nail plate where the nail and the skin meet). This sign may mean there is melanoma in the nail bed (the soft tissue underneath the nail plate that attaches the nail to the finger). When this sign is present, doctors do a biopsy of the nail bed abnormality. Melanoma may also occur in the absence of the Hutchinson sign

  • Track 4-1Paronychia, warts, and green nail syndrome
  • Track 4-2Fingernail and Toenail Injury
  • Track 4-3Ingrown toenail
  • Track 4-4Onychomycosis
  • Track 4-5Dystrophy
  • Track 4-6Benign Tumors and Pseudotumors of the Nail

Long‐term utilization of immunosuppression in organ transplant recipients (OTRs) leads to decreased immune‐mediated tumour surveillance and development of malignant tumours a delicate balance needs to be maintained in the intensity of immunosuppression to keep the risk of malignancy low without jeopardizing life‐saving graft function. OTRs are prone to developing skin cancers that exhibit unique epidemiologic, pathophysiologic, and prognostic characteristics

  • Track 5-1Squamous Cell Carcinoma
  • Track 5-2Skin cancer screening
  • Track 5-3Pathogenesis
  • Track 5-4Actinic Keratoses
  • Track 5-5Systemic chemoprophylaxis
  • Track 5-6Staging of cutaneous SCCs
  • Track 5-7Metastatic Cutaneous SCC
  • Track 5-8Kaposi Sarcoma
  • Track 5-9Merkel Cell Carcinoma
  • Track 5-10Rare Cutaneous Tumours

BCCs are abnormal, uncontrolled growths or lesions that arise in the skin’s basal cells, which line the deepest layer of the epidermis (the outermost layer of the skin). BCCs often look like open sores, red patches, pink growths, shiny bumps, or scars and are usually caused by a combination of cumulative and intense, occasional sun exposure.

BCC almost never spreads (metastasizes) beyond the original tumor site. Only in exceedingly rare cases can it spread to other parts of the body and become life-threatening. It shouldn’t be taken lightly, though: it can be disfiguring if not treated promptly.

  • Track 6-1Basal Cell Carcinoma - Causes and Risk Factors
  • Track 6-2Basal Cell Carcinoma Preventions
  • Track 6-3Basal Cell Carcinoma Treatment
  • Track 6-4Signs of Basal Cell Carcinoma

Mohs surgery is one of the most precisely used surgical techniques which is used to treat skin cancer. While Mohs surgery, thin layers of cancer-containing skin are progressively removed and then further examined until only cancer-free tissue remains. Mohs surgery is also known as Mohs micrographic surgery. Skin cancer is also included in this session and all the other skin related disorders and surgeries will be covered.

  • Track 7-1Cryosurgery
  • Track 7-2Dermabrasion
  • Track 7-3Imiquimod
  • Track 7-4Surgery
  • Track 7-5Chemotherapy
  • Track 7-6Debridement

A skin biopsy is a procedure in which a doctor cuts and removes a small sample of skin to have it tested to diagnose the cells appropriate apoptosis. This sample helps doctor diagnose diseases such as skin cancer, infection, or other skin disorders.

  • Track 8-1Shave biopsy
  • Track 8-2Punch biopsy
  • Track 8-3Excisional biopsy
  • Track 8-4Incisional biopsy

Dermatopathology is a joint subspecialty of dermatology and pathology or surgical pathology that focuses on the study of cutaneous diseases at a microscopic and molecular level. It also encompasses analyses of the potential causes of skin diseases at a basic level. Dermatopathologists work in close association with clinical dermatologists, with many possessing further clinical training in dermatology.

Dermatologists are able to recognize most skin diseases based on their appearances, anatomic distributions, and behaviour. Sometimes, however, those criteria do not allow a conclusive diagnosis to be made, and a skin biopsy is taken to be examined under the microscope are subject to other molecular tests. That process reveals the histology of the disease and results in a specific diagnostic interpretation. In some cases, additional specialized testing needs to be performed on biopsies

  • Track 9-1Immunofluorescence
  • Track 9-2Immunohistochemistry
  • Track 9-3Electron microscopy
  • Track 9-4Flow cytometry
  • Track 9-5Molecular-pathologic analysis

Epidemiology is the study of the distribution and causes of diseases in human populations. In addition to describing the burden and causes of skin diseases in populations, clinical epidemiology is concerned with describing the natural history and prognosis of diseases and with evaluating interventions which seek to prevent or treat diseases. The term dermatoepidemiology refers to the study of the epidemiology of dermatological disorders.